Fresenius
Financials
2021 Annual Revenue
€17.62 Billion
2021 Gross Profit
€5.08 Billion
2021 Annual Net Income
€969 million
2021 Number of Locations
4,171
2021 Number of Employees
122,909
Credit Rating
S&P Rated: Investment Grade Baa3 (Long-Term)
Fresenius
Fresenius Medical Care (NYSE: FMS) provides dialysis related products, inpatient/outpatient care products, and services such as engineering to hospitals and related facilities. Fresenius operates 4,171 dialysis centers in North America and has over 122,000 employees. These facilities routinely provide medically necessary renal care to hundreds of thousands of patients with chronic kidney failure, a condition that affects more than 2.1 million individuals globally.